Microfluidic device capable of trapping rare circulating tumor cells from blood of cancer patients
In 2007, Mehmet Toner and Daniel Haber and their collaborators at Massachusetts General Hospital and Harvard Medical School developed a microfluidic device capable of trapping rare circulating tumor cells from the blood of cancer patients.
As a way of simplifying lab-on-a-chip devices for superior medical tests, University of Michigan researchers have created microfluidic integrated circuits.